Clinical Trial: Preclinical Safety Evaluation and First-in-Human Translational Study of [177Lu]Lu-TEFAPI-06

U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07299253) titled 'Preclinical Safety Evaluation and First-in-Human Translational Study of [177Lu]Lu-TEFAPI-06' on Nov. 26.

Brief Summary: This study aims to systematically evaluate the safety, biodistribution, dosimetry, and preliminary therapeutic potential of [177Lu]Lu-TEFAPI-06 through an exploratory first-in-human (FIH) trial.

Study Start Date: Aug. 16, 2023

Study Type: INTERVENTIONAL

Condition: Metastatic Solid Tumors (Any Localization)

Intervention: DRUG: radionuclide therapy with [177Lu]Lu--TEFAPI-06

A Novel Albumin-Binding FAPI Radiopharmaceutical for Theranostics

Recruitment Status: COMPLETED

Sponsor: Lanzhou University Second Hospi...